Decreased susceptibilities to retapamulin, mupirocin, and chlorhexidine among staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 5, 2014, Pages 2878-2883

  McNeil, J Chase ^a   Hulten, Kristina G ^a   Kaplan, Sheldon L ^a   Mason, Edward O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; CLINDAMYCIN; COTRIMOXAZOLE; LINEZOLID; OXACILLIN; PSEUDOMONIC ACID; RETAPAMULIN; VANCOMYCIN; FUSED HETEROCYCLIC RINGS;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BROTH DILUTION; CHILD; CROSS RESISTANCE; EPSILOMETER TEST; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; ADULT; AGED; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PATHOGENICITY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; CHLORHEXIDINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUPIROCIN; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84898636348     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02707-13     Document Type: Article

References (34)

1. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674. http://dx.doi.org/10.1056/ NEJMoa055356.
2. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Talan MJRDA, Chambers HF. 2011. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin. Infect. Dis. 52:285-292. http://dx.doi.org/10.1093/cid/cir034.
3. McNeil JC, Hulten KG, Kaplan SL, Mason EO. 2011. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. Antimicrob. Agents Chemother. 55:2431-2433. http://dx.doi.org/10.1128/ AAC.01587-10.
4. Fritz SA, Hogan PG, Camins BC, Ainsworth AJ, Patrick C, Martin MS, Krauss MJ, Rodriguez M, Burnham CA. 2013. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob. Agents Chemother. 57:559-568. http://dx.doi.org/10.1128/ AAC.01633-12.
5. Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, Obeng D, Reich NG, Coffin SE, Perl TM. 2013. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, clusterrandomised, crossover trial. Lancet 381:1099-1106. http://dx.doi.org/10.1016/S0140-6736(12) 61687-0.
6. McNeil JC, Hulten KG, Kaplan SL, Mahoney DH, Mason EO. 2013. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr. Infect. Dis. J. 32:124-128. http://dx.doi.org/10.1097/INF.0b013e318271c4e0.
7. McNeil JC, Ligon JA, Hulten KG, Dreyer WJ, Heinle J, Mason EO, Kaplan SL. 11 July 2013. Staphylococcus aureus infections in children with congenital heart disease. J. Pediatr. Infect. Dis. Soc. http://dx.doi.org/10.1093/jpids/ pit037.
8. Costa SS, Viveiros M, Amaral L, Couto I. 2013. Multidrug efflux pumps in Staphylococcus aureus: an update. Open Microbiol. J. 7:59-71. http://dx.doi.org/10.2174/1874285801307010059.
9. Kosmidis C, Schindler BD, Jacinto PL, Patel D, Bains K, Seo SM, Kaatz GW. 2012. Expression of multidrug resistance efflux pump genes in clinical and environmental isolates of Staphylococcus aureus. Int. J. Antimicrob. Agents 40:204-209. http://dx.doi.org/10.1016/j.ijantimicag.2012.04.014.
10. Fritz SA, Hogan PG, Hayek G, Eisenstein KA, Rodriguez M, Epplin EK, Garbutt J, Fraser VJ. 2012. Household versus individual approaches to eradication of community-Associated Staphylococcus aureus in children: a randomized trial. Clin. Infect. Dis. 54:743-751. http://dx.doi.org/10.1093/cid/ cir919.
11. Fritz SA, Camins BC, Eisenstein KA, Fritz JM, Epplin EK, Burnham CA, Dukes J, Storch GA. 2011. Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-Associated skin and soft-tissue infections: a randomized trial. Infect. Control Hosp. Epidemiol. 32:872-880. http://dx.doi.org/10.1086/661285.
12. Gentry DR, McCloskey L, Gwynn MN, Rittenhouse SF, Scangarella N, Shawar R, Holmes DJ. 2008. Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus. Antimicrob. Agents Chemother. 52:4507-4509. http://dx.doi.org/10.1128/AAC.00915-08.
13. Long KS, Poehlsgaard J, Kehrenberg C, Schwarz S, Vester B. 2006. The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob. Agents Chemother. 50:2500-2505. http://dx.doi.org/10.1128/AAC.00131-06.
14. Miller K, Dunsmore CJ, Fishwick CW, Chopra I. 2008. Linezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center. Antimicrob. Agents Chemother. 52:1737-1742. http://dx.doi.org/10.1128/AAC.01015-07.
15. Woodford N, Afzal-Shah M, Warner M, Livermore DM. 2008. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin. J. Antimicrob. Chemother. 62:766-768. http://dx.doi.org/10.1093/ jac/dkn266.
16. Saravolatz LD, Pawlak J, Saravolatz SN, Johnson LB. 24 June 2013. In vitro activity of retapamulin against Staphylococcus aureus resistant to various antimicrobial agents. Antimicrob. Agents Chemother. http://dx.doi.org/10.1128/ AAC.00282-13.
17. Kaplan SL, Hulten KG, Gonzalez BE, Hammerman WA, Lamberth L, Versalovic J, Mason EO, Jr. 2005. Three-year surveillance of communityacquired Staphylococcus aureus infections in children. Clin. Infect. Dis. 40:1785-1791. http://dx.doi.org/10.1086/430312.
18. Hyun DY, Mason EO, Forbes A, Kaplan SL. 2009. Trimethoprimsulfamethoxazole or clindamycin for treatment of communityacquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr. Infect. Dis. J. 28:57-59. http://dx.doi.org/10.1097/INF. 0b013e3181826e5e.
19. CLSI. 2010. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20-U. CLSI, Wayne, PA.
20. Traczewski MM, Brown SD. 2008. Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent. Antimicrob. Agents Chemother. 52:3863-3867. http://dx.doi.org/10.1128/AAC.00399-08.
21. Eltringham I. 1997. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J. Hosp. Infect. 35:1-8. http://dx.doi.org/10. 1016/S0195-6701(97)90162-6.
22. Noguchi N, Hase M, Kitta M, Sasatsu M, Deguchi K, Kono M. 1999. Antiseptic susceptibility and distribution of antiseptic-resistance genes in methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 172: 247-253. http://dx.doi.org/10.1111/j.1574-6968.1999.tb13475.x.
23. Hulten KG, Kaplan SL, Gonzalez BE, Hammerman WA, Lamberth LB, Versalovic J, Mason EO, Jr. 2006. Three-year surveillance of community onset health care-Associated staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 25:349-353. http://dx.doi.org/10.1097/01.inf.0000207404.50143.1e.
24. Gomez-Sanz E, Torres C, Lozano C, Fernandez-Perez R, Aspiroz C, Ruiz-Larrea F, Zarazaga M. Detection, molecular characterization, and clonal diversity of methicillin-resistant Staphylococcus aureus CC398 and CC97 in Spanish slaughter pigs of different age groups. Foodborne Pathog. Dis. 7:1269-1277. http://dx.doi.org/10.1089/fpd.2010.0610.
25. Schwendener S, Perreten V. 2011. New transposon Tn6133 in methicillin-resistant Staphylococcus aureus ST398 contains vga(E), a novel streptogramin A, pleuromutilin, and lincosamide resistance gene. Antimicrob. Agents Chemother. 55:4900-4904. http://dx.doi.org/10.1128/AAC.00528-11.
26. Diep BAHFC, Graber CJ, Szumowski JD, Miller LG, Han LL, Chen JH, Lin F, Phan THV, Carleton HA, McDougal LK, Tenover FC, Cohen DE, Mayer KH, Sensabaugh GF, Perdreau-Remington F. 2008. Emergence of multidrug-resistant, community-Associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann. Intern. Med. 148:249-257. http://dx.doi.org/10.7326/0003-4819-148-4-200802190-00204.
27. Seah C, Alexander DC, Louie L, Simor A, Low DE, Longtin J, Melano RG. 2012. MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus. Antimicrob. Agents Chemother. 56:1916-1920. http://dx.doi.org/10.1128/ AAC.05325-11.
28. Kosowska-Shick K, Clark C, Credito K, McGhee P, Dewasse B, Bogdanovich T, Appelbaum PC. 2006. Single-And multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes. Antimicrob. Agents Chemother. 50:765-769. http://dx.doi.org/10.1128/AAC.50.2.765-769.2006.
29. Cadilla A, David MZ, Daum RS, Boyle-Vavra S. 2011. Association of high-level mupirocin resistance and multidrug-resistant methicillinresistant Staphylococcus aureus at an academic center in the midwestern United States. J. Clin. Microbiol. 49:95-100. http://dx.doi.org/10.1128/JCM.00759-10.
30. Udo EE, Jacob LE, Mathew B. 2001. Genetic analysis of methicillinresistant Staphylococcus aureus expressing high-And low-level mupirocin resistance. J. Med. Microbiol. 50:909-915.
31. Long KS, Hansen LH, Jakobsen L, Vester B. 2006. Interaction of pleuromutilin derivatives with the ribosomal peptidyl transferase center. Antimicrob. Agents Chemother. 50:1458-1462. http://dx.doi.org/10.1128/AAC.50.4. 1458-1462.2006.
32. Champney WS, Rodgers WK. 2007. Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. Antimicrob. Agents Chemother. 51:3385-3387. http://dx.doi.org/10.1128/AAC.00475-07.
33. Lozano C, Aspiroz C, Rezusta A, Gomez-Sanz E, Simon C, Gomez P, Ortega C, Revillo MJ, Zarazaga M, Torres C. 2012. Identification of novel vga(A)-carrying plasmids and a Tn5406-like transposon in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis of human and animal origin. Int. J. Antimicrob. Agents 40:306-312. http://dx.doi.org/10.1016/j.ijantimicag.2012.06. 009.
34. Kadlec K, Pomba CF, Couto N, Schwarz S. 2010. Small plasmids carrying vga(A) or vga(C) genes mediate resistance to lincosamides, pleuromutilins and streptogramin A antibiotics in methicillinresistant Staphylococcus aureus ST398 from swine. J. Antimicrob. Chemother. 65:2692-2693. http://dx.doi.org/10.1093/ jac/dkq365.